Bessemer Group Inc Abbott Laboratories Transaction History

Bessemer Group Inc

$60.7 Billion
Q3 2024

A detailed history of Bessemer Group Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Bessemer Group Inc holds 1,320,178 shares of ABT stock, worth $152 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares

1,320,178

Previous 1,283,609 2.85%

Holding current value

$152 Million

Previous $133 Million 12.85%

% of portfolio

0.25%

Previous 0.24%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$100.07 - $118.13 $3.66 Million - $4.32 Million	36,569 Added 2.85%	1,320,178 $151 Million
Q2 2024 Aug 13, 2024	SELL	$100.73 - $112.44 $1.59 Million - $1.78 Million	-15,794 Reduced 1.22%	1,283,609 $133 Million
Q1 2024 May 13, 2024	SELL	$109.52 - $120.96 $4.39 Million - $4.85 Million	-40,089 Reduced 2.99%	1,299,403 $148 Million
Q4 2023 Feb 09, 2024	SELL	$90.19 - $110.4 $855,181 - $1.05 Million	-9,482 Reduced 0.7%	1,339,492 $147 Million
Q3 2023 Nov 13, 2023	SELL	$95.53 - $114.62 $121,896 - $146,255	-1,276 Reduced 0.09%	1,348,974 $131 Million
Q2 2023 Aug 10, 2023	BUY	$100.78 - $112.29 $1.38 Million - $1.54 Million	13,686 Added 1.02%	1,350,250 $147 Million
Q1 2023 May 10, 2023	BUY	$96.86 - $114.01 $704,559 - $829,308	7,274 Added 0.55%	1,336,564 $135 Million
Q4 2022 Feb 13, 2023	BUY	$95.06 - $111.52 $21.3 Million - $25 Million	224,295 Added 20.3%	1,329,290 $146 Million
Q3 2022 Nov 09, 2022	BUY	$96.76 - $112.03 $24.4 Million - $28.3 Million	252,470 Added 29.61%	1,104,995 $107 Million
Q2 2022 Aug 10, 2022	BUY	$102.07 - $123.37 $1.67 Million - $2.02 Million	16,388 Added 1.96%	852,525 $92.6 Million
Q1 2022 May 12, 2022	BUY	$114.02 - $139.04 $31.8 Million - $38.8 Million	278,832 Added 50.03%	836,137 $99 Million
Q4 2021 Jan 27, 2022	BUY	$115.53 - $141.46 $1.47 Million - $1.8 Million	12,713 Added 2.33%	557,305 $78.4 Million
Q3 2021 Nov 12, 2021	BUY	$116.66 - $129.06 $1.04 Million - $1.15 Million	8,941 Added 1.67%	544,592 $64.3 Million
Q2 2021 Aug 06, 2021	BUY	$105.79 - $124.53 $2.04 Million - $2.4 Million	19,293 Added 3.74%	535,651 $62.1 Million
Q1 2021 May 13, 2021	BUY	$108.84 - $128.23 $2.42 Million - $2.85 Million	22,190 Added 4.49%	516,358 $61.9 Million
Q4 2020 Feb 09, 2021	SELL	$105.0 - $114.42 $27,300 - $29,749	-260 Reduced 0.05%	494,168 $54.1 Million
Q3 2020 Nov 12, 2020	BUY	$91.64 - $111.29 $4.96 Million - $6.02 Million	54,126 Added 12.29%	494,428 $53.8 Million
Q2 2020 Aug 05, 2020	BUY	$76.57 - $98.0 $888,901 - $1.14 Million	11,609 Added 2.71%	440,302 $40.3 Million
Q1 2020 Apr 30, 2020	BUY	$62.82 - $91.86 $245,374 - $358,805	3,906 Added 0.92%	428,693 $33.8 Million
Q4 2019 Feb 04, 2020	SELL	$78.51 - $87.4 $1.2 Million - $1.33 Million	-15,222 Reduced 3.46%	424,787 $36.9 Million
Q3 2019 Nov 07, 2019	SELL	$81.84 - $88.74 $292,578 - $317,245	-3,575 Reduced 0.81%	440,009 $36.8 Million
Q2 2019 Jul 19, 2019	SELL	$72.88 - $85.0 $83,957 - $97,920	-1,152 Reduced 0.26%	443,584 $37.3 Million
Q1 2019 May 13, 2019	BUY	$66.22 - $80.06 $718,288 - $868,410	10,847 Added 2.5%	444,736 $35.6 Million
Q4 2018 Feb 12, 2019	BUY	$65.56 - $74.27 $25.2 Million - $28.5 Million	383,801 Added 766.25%	433,889 $31.4 Million
Q3 2018 Nov 06, 2018	BUY	$60.81 - $73.36 $107,208 - $129,333	1,763 Added 3.65%	50,088 $3.68 Million
Q2 2018 Jul 25, 2018	SELL	$57.57 - $63.54 $61,196 - $67,543	-1,063 Reduced 2.15%	48,325 $2.95 Million
Q1 2018 May 10, 2018	SELL	$56.27 - $63.62 $229,243 - $259,187	-4,074 Reduced 7.62%	49,388 $2.96 Million
Q4 2017 Jan 30, 2018	BUY	$53.68 - $57.47 $99,952 - $107,009	1,862 Added 3.61%	53,462 $3.05 Million
Q3 2017 Nov 03, 2017	BUY	$48.06 - $53.64 $2.48 Million - $2.77 Million	51,600	51,600 $2.75 Million

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $201B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bessemer Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bessemer Group Inc with notifications on news.

Account

Bessemer Group Inc Abbott Laboratories Transaction History